Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Ji'An, Jiangxi
- Most recent report
- 6-K, filed Oct 6, 2026
- Filings on record
- 119 filings
- On EDGAR
- CIK 1809616
- Fiscal year ends
- September
- Filer status
- Non-accelerated filer, Emerging growth company
Financials 8 of 54
- 6-K Report a foreign issuer made public elsewhere Oct 6, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 1, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 31, 2026
- 6-K Report a foreign issuer made public elsewhere Jul 29, 2026
- 6-K Report a foreign issuer made public elsewhere Jun 26, 2026
- 6-K Report a foreign issuer made public elsewhere May 14, 2026
- 6-K Report a foreign issuer made public elsewhere Apr 16, 2026
- 6-K Report a foreign issuer made public elsewhere Feb 11, 2026
Prospectuses and Registrations 8 of 11
- F-3 Sep 29, 2026
- 424B5 Prospectus supplement for an offering Dec 9, 2024
- 424B4 Final prospectus for an offering Jun 25, 2024
- F-1 Registration statement, foreign issuer Apr 24, 2024
- F-3 Oct 27, 2022
- 424B4 Final prospectus for an offering Mar 24, 2021
- FWP Free writing prospectus Mar 1, 2021
- FWP Free writing prospectus Mar 1, 2021
Ownership 8 of 23
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
- SCHEDULE 13G Large holder reported a passive stake Sep 1, 2026
Other 8 of 31
- EFFECT Notice that a registration became effective Oct 9, 2026
- 6-K/A Report a foreign issuer made public elsewhere, amended Sep 3, 2026
- NT 20-F Jan 27, 2025
- EFFECT Notice that a registration became effective Jun 7, 2024
- CORRESP Reply to SEC staff Jun 5, 2024
- CORRESP Reply to SEC staff May 14, 2024
- F-1/A Registration statement, foreign issuer, amended May 14, 2024
- UPLOAD Comment letter from SEC staff May 8, 2024
Everything here comes from Universe Pharmaceuticals INC's own filings on SEC EDGAR. The filing list is rechecked every hour.